These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15880078)

  • 1. Recombinant human growth hormone treatment after liver transplantation in childhood: the 5-year outcome.
    Puustinen L; Jalanko H; Holmberg C; Merenmies J
    Transplantation; 2005 May; 79(9):1241-6. PubMed ID: 15880078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology.
    Maxwell H; Rees L
    Arch Dis Child; 1998 Dec; 79(6):481-7. PubMed ID: 10210991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation.
    Sarna S; Sipilä I; Rönnholm K; Koistinen R; Holmberg C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1476-82. PubMed ID: 8636354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of growth after growth hormone treatment in children who undergo liver transplantation.
    Rodeck B; Kardorff R; Melter M; Ehrich JH
    J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):286-90. PubMed ID: 10997374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology.
    Guest G; Bérard E; Crosnier H; Chevallier T; Rappaport R; Broyer M
    Pediatr Nephrol; 1998 Aug; 12(6):437-46. PubMed ID: 9745864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group.
    Fine RN; Brown DF; Kuntze J; Wooster P; Kohaut EE
    J Pediatr; 1996 Dec; 129(6):883-91. PubMed ID: 8969731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of growth hormone treatment on a Belgian population of short children with renal allografts.
    Janssen F; Van Damme-Lombaerts R; Van Dyck M; Hall M; Schurmans T; Herman J; Hooghe L; Van Damme B
    Pediatr Transplant; 1997 Nov; 1(2):190-6. PubMed ID: 10084780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment.
    Lanes R; Gunczler P; Orta N; Bosquez M; Scovino R; Dominguez L; Esaa S; Weisinger JR
    Horm Res; 1996; 46(6):263-8. PubMed ID: 8982736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of the response to growth hormone in short prepubertal children post-renal transplant. German Study Group for Growth Hormone Treatment in Children Post Renal Transplantation Study Group Members.
    Tönshoff B; Haffner D; Albers N; Offner G; Mehls O
    Br J Clin Pract Suppl; 1996 Aug; 85():34-7. PubMed ID: 8995027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
    Rothenbuhler A; Esterle L; Gueorguieva I; Salles JP; Mignot B; Colle M; Linglart A
    Growth Horm IGF Res; 2017 Oct; 36():11-15. PubMed ID: 28822957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
    Rogol AD; Cohen P; Weng W; Kappelgaard AM; Germak JA
    Horm Res Paediatr; 2013; 80(1):28-37. PubMed ID: 23816571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG; Brown R; Baum M
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of recombinant human growth hormone therapy in pediatric intestinal transplant recipients.
    Vo HD; Elrokhsi SH; Iverson AK; Keck MA
    Pediatr Transplant; 2022 Sep; 26(6):e14321. PubMed ID: 35587547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
    Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
    Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience--a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study.
    Mentser M; Breen TJ; Sullivan EK; Fine RN
    J Pediatr; 1997 Jul; 131(1 Pt 2):S20-4. PubMed ID: 9255222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.